IgE crosslinkage of Fcε receptor I induces both production and activation of matrix metalloproteinase-9 in mast cells

Cellular Immunology

Volumn 228, Issue 1, 2004, Pages 66-75

  Tanaka, Akane ^a   Matsuda, Hiroshi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Allergic inflammation; Cytokine; Degranulation; Extra cellular matrix; Serine protease

Indexed keywords

FC RECEPTOR; GELATINASE B; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC EPSILON RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE INHIBITOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; ANTIGEN; COLLAGENASE; CYTOKINE; DEXAMETHASONE; ENZYME PRECURSOR; IMMUNOGLOBULIN E RECEPTOR; MESSENGER RNA; PRO MATRIX METALLOPROTEINASE 9; PRO-MATRIX METALLOPROTEINASE 9; SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; CROSS LINKING; CYTOKINE PRODUCTION; DISEASE EXACERBATION; ENZYME ACTIVATION; ENZYME SYNTHESIS; EXTRACELLULAR MATRIX; INFLAMMATORY INFILTRATE; MAST CELL DEGRANULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; TISSUE DEGENERATION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; IMMUNOLOGY; MAST CELL; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; STEM CELL;

MURINAE;

ANIMALS; ANTIGENS; BONE MARROW CELLS; COLLAGENASES; CYTOKINES; DEXAMETHASONE; ENZYME ACTIVATION; ENZYME PRECURSORS; IMMUNOGLOBULIN E; MAST CELLS; MATRIX METALLOPROTEINASE 9; MICE; RECEPTORS, IGE; RNA, MESSENGER; SERINE PROTEINASE INHIBITORS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 2942585298     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellimm.2004.03.009     Document Type: Article

References (53)

1. Galli S.J. New concepts about the mast cell. N. Engl. J. Med. 28:1993;257-265
2. Galli S.J. Mast cells and basophils. Curr. Opin. Hematol. 7:2000;32-39
3. v mice to acquire resistance against larval Haemophysalis longicornis ticks J. Parasitol. 71:1985;443-448
4. Malaviya R., Ikeda T., Ross E., Abraham S.N. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection though TNF-α Nature. 381:1996;77-80
5. Galli S.J., Maurer M., Lantz C.R. Mast cells as sentinels of innate immunity. Curr. Opin. Immunol. 11:1999;53-59
6. Loveren H.V., Redegeld F., Matsuda H., Buckley T., Teppema J.S., Garssen J. Mast cells. Bos J.D. Skin Immune System. 1997;159-184 CRC Press, USA
7. Hamawy M.M., Mergenhagen S.E., Siraganian R.P. Protein tyrosine phosphorylation as a mechanism of signaling in mast cells and basophils. Cell. Signal. 6:1995;535-544
8. Graham T.E., Pfeiffer J.R., Lee R.J., Kusewitt D.F., Martinez A.M., Foutz T., Wilson B.S., Oliver J.M. MEK and ERK activation in ras-disabled RBL-2H3 mast cells and novel roles for geranylgeranylated and farnesylated proteins in FcεRI-mediated signaling. J. Immunol. 161:1998;6733-6744
9. Kawakami Y., Hartman S.E., Holland P.M., Cooper J.A., Kawakami T. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7. J. Immunol. 161:1998;1795-1802
10. Gu H., Saito K., Klaman L.D., Shen J., Fleming T., Wang Y., Pratt J.C., Lin G., Lim B., Kinet J.P., Neel B.G. Essential role for Gab2 in the allergic response. Nature. 412:2001;86-90
11. Pawanker R., Okuda M., Yssel H., Okumura K., Ra C. Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the FcεRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J. Clin. Invest. 99:1997;1492-1499
12. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsuzuki M., Hiroi J., Matsumoto M., Ushio H., Saito S., Askenase P.W., Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9:1997;461-466
13. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., Ishizaka K. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J. Immunol. 164:2000;3855-3861
14. Williams C.M., Galli S.J. Mast cell can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192:2000;455-462
15. Matsuda H., Kannan Y., Ushio H., Kiso Y., Kanemoto T., Suzuki H., Kitamura Y. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J. Exp. Med. 174:1991;7-14
16. Kip1 in proliferation of mast cells induced by interleukin-3 but not stem cell factor. Exp. Hematol. 29:2001;803-811
17. Flanagan J.G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 63:1990;185-194
18. Nocka K., Buck J., Levi E., Besmer P. Candidate ligand for the c-kit transmembrane kinase receptor: KL, a fibroblast derived growth factor stimulates mast cells and erythroid progenitors. EMBO J. 9:1990;3287-3294
19. Meininger C.J., Yana H., Rottapel R., Bernstein A., Zsebo K.M., Zettre B.R. The c-kit receptor ligand functions as a mast cell chemoattractant. Blood. 79:1992;958-963
20. Dastych J., Metcalfe D.D. Stem cell factor induces mast cell adhesion to fibronectin. J. Immunol. 152:1994;213-219
21. Kinashi T., Springer T.A. Steel factor and c-kit regulate cell-matrix adhesion. Blood. 83:1994;1033-1038
22. Kitamura Y., Tsujimura T., Jippo T., Kasugai T., Kanakura Y. Regulation of development, survival and neoplastic growth of mast cells though the c-kit receptor. Int. Arch. Allergy Immunol. 107:1995;54-56
23. Mierke C.T., Ballmaier M., Werner U., Manns M.P., Welte K., Bischoff S.C. Human endothelial cells regulate survival and proliferation of human mast cells. J. Exp. Med. 192:2000;801-811
24. Tanaka A., Arai K., Kitamura Y., Matsuda H. Matrix metelloproteinase-9 production, a newly identified function of mast cell progenitors, is down-regulated by c-kit receptor activation. Blood. 94:1999;2390-2395
25. Kanbe N., Tanaka A., Kanbe M., Itakura A., Kurosawa M., Matsuda H. Human mast cells produce matrix metalloproteinase 9. Eur. J. Immunol. 29:1999;2645-2649
26. Goetzl E.J., Banda M.J., Leppert D. Matrix metalloproteinase in immunity. J. Immunol. 156:1996;1-4
27. Werb Z. ECM and cell surface proteolysis: regular cellular ecology. Cell. 91:1997;439-442
28. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Collie E., Masure S., Proost P., Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69:2001;851-859
29. Leppert D., Waubant E., Galardy R., Bunnett N.W., Hauser S.T. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154:1995;4379-4389
30. Okada S., Kita H., George T.J., Gleich G.J., Leiferman K.M. Migration of eosinophils though basement membrane components in vitro: role of matrix metalloproteinase-9. Am. J. Respir. Cell Mol. Biol. 17:1997;519-528
31. Ahens D., Koch A.E., Pope R.M., Stein-Picarella M., Niedbala M.J. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 39:1996;1576-1587
32. Kelly E.A., Busse W.W., Jarjour N.N. Increased matrix metalloproteinase-9 in the airway after allergen challenges. Am. J. Respir. Crit. Care Med. 162:2000;1157-1161
33. Liu Z., Shipley J.M., Vu T.H., Zhou X., Diaz L.A., Werb Z., Senior R.M. Gelatinase B deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188:1998;475-482
34. Galis Z.S., Sukhova G.K., Lark M.W., Libby P. Increased expression of matrix metalloproteinase and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:1994;2493-2503
35. Basbaum C.B., Werb Z. Focalized proteolysis: spatial and temporal regulation of extra cellular matrix degradation at the cell surface. Curr. Opin. Cell Biol. 8:1996;731-738
36. Murphy G., Stanton H., Cowell S., Butler G., Knauper V., Atkinson S., Gavrilovic J. Mechanisms for pro matrix metalloproteinase activation. APMIS. 107:1999;38-44
37. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behendtsen O., Werb Z., Caughey G.H., Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13:1999;1382-1397
38. Lijnen H.R., Silence J., van Hoef B., Collen D. Matrix metalloproteinase 3 (stromelysin) independent gelatinase expression and activation in mice. Blood. 91:1998;2045-2053
39. Zhang Y., McCluskey K., Fujii K., Wahl L.M. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-1β though prostaglandin-dependent and -independent mechanisms. J. Immunol. 161:1998;3071-3076
40. Lane W.J., Dias S., Hattori K., Heissig B., Choy M., Rabbany S.Y., Wood J., Moore M.A., Rafii S. Stromal-derived factor 1-induced megakaryocyte migration and platelet production is dependent on matrix metalloproteinases. Blood. 96:2000;4152-4159
41. Ortega E., Hazan B., Zor U., Pecht I. Mast cell stimulation by monoclonal antibodies specific for the Fcε receptor yields distinct responses of arachidonic acid and leukotriene C4 secretion. Eur. J. Immunol. 19:1989;2251-2256
42. Fang K.C., Raymond W.W., Lazarus S.C., Caughey G.H. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97:1996;1589-1596
43. 92 bonds of the catalytic domain. J. Biol. Chem. 272:1997;25628-25635
44. Urata H., Kinoshita A., Misono K.S., Bumpus F.M., Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265:1990;22348-22357
45. Mendis A.H., Venaille T.J., Robinson B.W. Study of human epithelial cell detachment and damage: effects of proteases and oxidants. Immunol. Cell Biol. 68:1990;95-105
46. Jozaki K., Kuriu A., Waki N., Adachi S., Yamatodani A., Tarui S., Kitamura Y. Proliferative potential of murine peritoneal mast cells after degranulation induced by compound 48/80, substance P, tetradecanoylphorbol acetate, or calcium ionophore A23187. J. Immunol. 145:1990;4252-4256
47. Matsuda H., Kitamura Y., Sonoda T., Imori T. Precursor of mast cells fixed in the skin of mice. J. Cell. Physiol. 108:1981;409-415
48. Rider L.G., Hirasawa N., Santini F., Beaven M.A. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J. Immunol. 157:1996;2374-2380
49. Eklund K.K., Humphies D.E., Xia Z., Ghildyal N., Friend D.S., Gross V., Stevens R.L. Glucocorticoids inhibit the cytokine-induced proliferation of mast cells, the high affinity IgE receptor-mediated expression of TNF-α, and the IL-10-induced expression of chymases. J. Immunol. 158:1997;4373-4380
50. Hultner L., Kolsh S., Stassen M., Kaspers U., Kremer J.P., Mailhammer R., Moeller J., Broszeit H., Schmitt E. In activated mast cells, IL-1 up-regulated the production of several Th-2 related cytokines including IL-9. J. Immunol. 164:2000;5556-5563
51. Stassen M., Arnold M., Hultner L., Muller C., Neudorfl C., Reineke T., Schmitt E. Murine bone marrow-derived mast cells as potent producers of IL-9: costimulatory function of IL-10 and kit ligand in the presence of IL-1. J. Immunol. 164:2000;5549-5555
52. Herrmann J.L., Menter D.G., Hamada J., Marchetti D., Nakajima M., Nicolson G.L. Mediation of NGF-stimulated extra cellular matrix invasion by the human melanoma low affinity p75 neurotrophin receptor: melanoma p75 functions independently of trk A. Mol. Biol. Cell. 4:1993;1205-1216
53. Jippo T., Morii E., Tsujino K., Tsujimura T., Lee Y.M., Kim D.K., Matsuda H., Kim H.M., Kitamura Y. Involvement of transcription factor encoded by the mouse mi locus (MITF) in expression of p75 receptor of nerve growth factor in cultured mast cells of mice. Blood. 90:1997;2601-2608